These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18326352)

  • 21. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Representations of MDR and XDR-TB in South African newspapers.
    Daku M; Gibbs A; Heymann J
    Soc Sci Med; 2012 Jul; 75(2):410-8. PubMed ID: 22534376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis drug resistance: a global threat.
    Nachega JB; Chaisson RE
    Clin Infect Dis; 2003 Jan; 36(Suppl 1):S24-30. PubMed ID: 12516027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensively drug-resistant tuberculosis.
    Madariaga MG; Lalloo UG; Swindells S
    Am J Med; 2008 Oct; 121(10):835-44. PubMed ID: 18823850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDR-/XDR-TB management: what it was, current standards and what is ahead.
    Monedero I; Caminero JA
    Expert Rev Respir Med; 2009 Apr; 3(2):133-45. PubMed ID: 20477307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tubercular disease: clinical aspects and drug resistance].
    Matteelli A; Apostoli A; Benedetti S; Marcantoni C; Carvalho AC
    G Ital Med Lav Ergon; 2010; 32(3):260-3. PubMed ID: 21061706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-line drug resistance in multidrug-resistant tuberculosis cases of various origins in the Netherlands.
    van Ingen J; Boeree MJ; Wright A; van der Laan T; Dekhuijzen PN; van Soolingen D
    Int J Tuberc Lung Dis; 2008 Nov; 12(11):1295-9. PubMed ID: 18926040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extensively drug-resistant tuberculosis].
    Lange C; Grobusch MP; Wagner D
    Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs.
    Laing RO; McGoldrick KM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S194-207. PubMed ID: 11144553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.
    Colebunders R; Worodria W; Jones-López E; Joloba M; Apers L; Ellner J
    Trop Med Int Health; 2008 Sep; 13(9):1204-7. PubMed ID: 18664238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-resistant TB poses global health threat, new report also finds TB control programs effective.
    Monday Dev; 1997 Nov; 15(22):4-5. PubMed ID: 12292816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.